Related Experiment Video
Updated: May 28, 2025

Murine Ileocolic Bowel Resection with Primary Anastomosis
Published on: October 29, 2014
Characterization of risk factors and postoperative pharmacological prophylaxis patterns affecting re-resection in
Xiaolong Ge1, Huaying Liu2, Wei Liu1
1Department of General Surgery, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, 3 East Qingchun Road, Hangzhou, 310016, Zhejiang, China.
Background:
Limited research has focused on the characterization of Crohn's disease (CD) patients with surgical recurrence. This study aimed to evaluate risk factors and postoperative pharmacological prophylaxis patterns for surgical recurrence in CD.
Methods:
Data were obtained from 349 CD patients over a 5-year follow-up after initial bowel surgery. Risk factors and postoperative pharmacological prophylaxis patterns affecting re-resection were analyzed. Multivariate Cox regression analysis was also used to identify risk factors for surgical recurrence. A nomogram was created to guide postoperative disease surveillance.
Results:
A total of 349 CD patients were enrolled, with a median follow-up time of 68.0 months after surgery. The overall cumulative risk of surgical recurrence was 9.7% at 5 years. In a multivariate Cox regression analysis, stricturing and penetrating behavior, extensive small bowel resection, residual lesions, postoperative complications, and postoperative step-up to biologic therapy were the factors independently associated with an increased risk of surgical recurrence (P < 0.05). A nomogram with these variables had good predictive accuracy for surgical recurrence (C-index = 0.767). Kaplan-Meier curves showed that patients with residual lesions had a higher probability of surgical recurrence (P = 0.004). Furthermore, there were significantly more patients who received early step-up to biologics after primary bowel surgery within 8 weeks in the no-recurrence group (P = 0.014).
Conclusion:
Several risk factors were found in CD patients with surgical recurrence, and a nomogram predicting surgical recurrence could guide individual postoperative management to avoid reoperations. Postoperative pharmacological prophylaxis patterns with early step-up to biologics might reduce the re-rection incidence.
More Related Videos
06:46Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
Published on: September 27, 2024
13:37A Mouse Tumor Model of Surgical Stress to Explore the Mechanisms of Postoperative Immunosuppression and Evaluate Novel Perioperative Immunotherapies
Published on: March 12, 2014
Related Concept Videos
Inflammatory Bowel Disease V: Surgical Management
Here are some common surgical interventions for IBD:
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Endoscopic Procedures IV: Sigmoidoscopy and Laproscopy
Sigmoidoscopy
Sigmoidoscopy is a diagnostic procedure that uses a flexible sigmoidoscope equipped with a light source and camera to examine the rectum and sigmoid colon. The procedure involves inserting the tube through the anus...
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...